200 related articles for article (PubMed ID: 18367670)
1. The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes.
Oak S; Gilliam LK; Landin-Olsson M; Törn C; Kockum I; Pennington CR; Rowley MJ; Christie MR; Banga JP; Hampe CS
Proc Natl Acad Sci U S A; 2008 Apr; 105(14):5471-6. PubMed ID: 18367670
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals.
Oak S; Radtke J; Törn C; Landin-Olsson M; Hampe CS
Scand J Immunol; 2011 Oct; 74(4):363-7. PubMed ID: 21517929
[TBL] [Abstract][Full Text] [Related]
3. Decline in titers of anti-idiotypic antibodies specific to autoantibodies to GAD65 (GAD65Ab) precedes development of GAD65Ab and type 1 diabetes.
Larsson HE; Jönsson I; Lernmark A; Ivarsson S; Radtke JR; Hampe CS; ;
PLoS One; 2013; 8(6):e65173. PubMed ID: 23785410
[TBL] [Abstract][Full Text] [Related]
4. Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse.
Wang X; Zhang A; Liu Y; Chen S; Feng Z; Shang W; Maziarz M; Radtke J; Hampe CS
PLoS One; 2012; 7(2):e32515. PubMed ID: 22384267
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three assays for the detection of GAD65Ab-specific anti-idiotypic antibodies.
Oak S; Radtke J; Landin-Olsson M; Törn C; Lernmark A; Hampe CS
J Immunol Methods; 2009 Dec; 351(1-2):55-61. PubMed ID: 19781546
[TBL] [Abstract][Full Text] [Related]
6. Masked and overt autoantibodies specific to the DPD epitope of 65-kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved β-cell functional reserve in ketosis-prone diabetes.
Oak S; Gaur LK; Radtke J; Patel R; Iyer D; Ram N; Gaba R; Balasubramanyam A; Hampe CS
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1040-4. PubMed ID: 24601691
[TBL] [Abstract][Full Text] [Related]
7. GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.
Liimatainen S; Honnorat J; Pittock SJ; McKeon A; Manto M; Radtke JR; ; Hampe CS
Orphanet J Rare Dis; 2018 Apr; 13(1):55. PubMed ID: 29636076
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.
Hampe CS; Hall TR; Agren A; Rolandsson O
Clin Exp Immunol; 2007 Apr; 148(1):72-8. PubMed ID: 17286757
[TBL] [Abstract][Full Text] [Related]
9. Detection of recombinant GAD65 and GAD67 antibodies using a simple radioimmunoassay.
Kawasaki E; Yano M; Abiru N; Akazawa S; Nagataki S
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):61-9. PubMed ID: 8803483
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.
Falorni A; Ackefors M; Carlberg C; Daniels T; Persson B; Robertson J; Lernmark A
Diabetologia; 1996 Sep; 39(9):1091-8. PubMed ID: 8877294
[TBL] [Abstract][Full Text] [Related]
11. Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity.
Ortqvist E; Brooks-Worrell B; Lynch K; Radtke J; Bekris LM; Kockum I; Agardh CD; Cilio CM; Lethagen AL; Persson B; Lernmark A; Reichow J; Oak S; Palmer JP; Hampe CS
J Clin Endocrinol Metab; 2010 Nov; 95(11):E310-8. PubMed ID: 20685858
[TBL] [Abstract][Full Text] [Related]
12. Epilepsy and behavioral changes, type 1 diabetes mellitus and a high titer of glutamic acid decarboxylase antibodies.
Ganelin-Cohen E; Modan-Moses D; Hemi R; Kanety H; Ben-Zeev B; Hampe CS
Pediatr Diabetes; 2016 Dec; 17(8):617-622. PubMed ID: 26711844
[TBL] [Abstract][Full Text] [Related]
13. Reduced display of conformational epitopes in the N-terminal truncated GAD65 isoform: relevance for people with stiff person syndrome or DQ8/8-positive Type 1 diabetes mellitus.
Hampe CS; Radtke JR; Wester A; Carlsson A; Cedervall E; Jönsson B; Ivarsson SA; Elding Larsson H; Larsson K; Lindberg B; Neiderud J; Rolandsson O; Lernmark Å
Diabet Med; 2019 Nov; 36(11):1375-1383. PubMed ID: 30264481
[TBL] [Abstract][Full Text] [Related]
14. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.
Reijonen H; Daniels TL; Lernmark A; Nepom GT
Diabetes; 2000 Oct; 49(10):1621-6. PubMed ID: 11016444
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus.
Walikonis JE; Lennon VA
Mayo Clin Proc; 1998 Dec; 73(12):1161-6. PubMed ID: 9868413
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
[TBL] [Abstract][Full Text] [Related]
17. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
[TBL] [Abstract][Full Text] [Related]
18. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
[TBL] [Abstract][Full Text] [Related]
19. Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset.
Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Persson B; Lernmark A
J Autoimmun; 2002 Feb; 18(1):49-53. PubMed ID: 11869046
[TBL] [Abstract][Full Text] [Related]
20. Multiplicity of the antibody response to GAD65 in Type I diabetes.
Gilliam LK; Binder KA; Banga JP; Madec AM; Ortqvist E; Kockum I; Luo D; Hampe CS
Clin Exp Immunol; 2004 Nov; 138(2):337-41. PubMed ID: 15498046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
